Sandi Bresnick is a trial lawyer and Co-Chair of the Firm's Global Life Sciences Practice. She focuses her practice on patent infringement and product liability actions and has particular experience litigating pharmaceutical and medical device cases.
Sandi has been recognized by Chambers USA as a leading individual in intellectual property every year since 2012 and has been similarly recognized by Chambers Global in 2016. Chambers has noted in various years that she is "an expert on the law concerning commercial life sciences, and is recognized as a leading patent and product liability litigator;" praised for her "superior technical understanding;" "above all a trial lawyer, and is much sought after by market-leading clients to represent them in medical devices and pharmaceuticals cases;" and "very bright and articulate as a first chair in patent jury trials."
Sandi has also been recognized in other guides and rankings, including IAM Patent 1000, which has reported she "has a knack for strategically positioning patent cases for trial. She also deftly handles product liability suits for life sciences entities, where her nuanced technical understanding proves a boon to clients."
Sandi has taught Pharmaceutical Patent Law at Rutgers University School of Law and is a member of the Board of Directors of The Progeria Research Foundation, a non-profit research organization dedicated to developing treatments and a cure for progeria.